The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity
Open accessAbstract
Adoptive immunotherapy using chimeric antigen receptor (CAR) expressing T cells targeting the CD19 B lineage receptor has demonstrated marked success in relapsed pre-B-cell acute lymphoblastic leukaemia (ALL). Persisting CAR-T cells generate sustained pressure against CD19 that may drive unique mechanisms of resistance. Pre-B ALL originates from a committed pre-B cell or an earlier progenitor, with potential to reprogram into other hematopoietic lineages. Here we report changes in lineage markers including myeloid conversion in patients following CD19 CAR therapy. Using murine ALL models we study the long-term effects of CD19 CAR-T cells and demonstrate partial or complete lineage switch as a consistent mechanism of CAR resistance depending on the underlying genetic oncogenic driver. Deletion of Pax5 or Ebf1 recapitulates lineage reprogramming occurring during CD19 CAR pressure. Our findings establish lineage switch as a mechanism of CAR resistance exposing inherent plasticity in genetic subtypes of pre-B-cell ALL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413
Vardiman, J. W., Thiele, J., Arber, D. A., Brunning, R. D., Borowitz, M. J., Porwit, A., Harris, N. L., Le Beau, M. M., Hellström-Lindberg, E., Tefferi, A., et al. (2009) · Blood · doi:10.1182/blood-2009-03-209262 · Cited by 4,424
Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia
Porter, D. L., Levine, B. L., Kalos, M., Bagg, A., & June, C. H. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103849 · Cited by 3,565
Lee, D. W., Kochenderfer, J. N., Stetler-Stevenson, M., Cui, Y. K., Delbrook, C., Feldman, S. A., Fry, T. J., Orentas, R., Sabatino, M., Shah, N. N., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61403-3 · Cited by 2,898
Self-citationEfficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Davila, M. L., Riviere, I., Wang, X., Bartido, S., Park, J., Curran, K., Chung, S. S., Stefanski, J., Borquez-Ojeda, O., Olszewska, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008226 · Cited by 2,476
Kochenderfer, J. N., Dudley, M. E., Kassim, S. H., Somerville, R. P. T., Carpenter, R. O., Stetler-Stevenson, M., Yang, J. C., Phan, G. Q., Hughes, M. S., Sherry, R. M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.2025 · Cited by 1,595
The Basic Principles of Chimeric Antigen Receptor Design
Sadelain, M., Brentjens, R., & Rivière, I. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0548 · Cited by 1,535
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Shlush, L. I., Zandi, S., Mitchell, A., Chen, W. C., Brandwein, J. M., Gupta, V., Kennedy, J. A., Schimmer, A. D., Schuh, A. C., Yee, K. W., et al. (2014) · Nature · doi:10.1038/nature13038 · Cited by 1,443
Kochenderfer, J. N., Wilson, W. H., Janik, J. E., Dudley, M. E., Stetler-Stevenson, M., Feldman, S. A., Maric, I., Raffeld, M., Nathan, D.-A. N., Lanier, B. J., et al. (2010) · Blood · doi:10.1182/blood-2010-04-281931 · Cited by 1,337
Sotillo, E., Barrett, D. M., Black, K. L., Bagashev, A., Oldridge, D., Wu, G., Sussman, R., Lanauze, C., Ruella, M., Gazzara, M. R., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1020 · Cited by 1,254
Self-citationCommitment to the B-lymphoid lineage depends on the transcription factor Pax5
Nutt, S. L., Heavey, B., Rolink, A. G., & Busslinger, M. (1999) · Nature · doi:10.1038/44076 · Cited by 1,179
Inaba, H., Greaves, M., & Mullighan, C. G. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62187-4 · Cited by 1,074
Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia
Mullighan, C. G., Phillips, L. A., Su, X., Ma, J., Miller, C. B., Shurtleff, S. A., & Downing, J. R. (2008) · Science · doi:10.1126/science.1164266 · Cited by 806
Gardner, R., Wu, D., Cherian, S., Fang, M., Hanafi, L.-A., Finney, O., Smithers, H., Jensen, M. C., Riddell, S. R., Maloney, D. G., et al. (2016) · Blood · doi:10.1182/blood-2015-08-665547 · Cited by 749
Self-citationPax5: the guardian of B cell identity and function
Cobaleda, C., Schebesta, A., Delogu, A., & Busslinger, M. (2007) · Nature Immunology · doi:10.1038/ni1454 · Cited by 702
Origins of chromosome translocations in childhood leukaemia
Greaves, M. F., & Wiemels, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1164 · Cited by 699
Antibody-modified T cells: CARs take the front seat for hematologic malignancies
Maus, M. V., Grupp, S. A., Porter, D. L., & June, C. H. (2014) · Blood · doi:10.1182/blood-2013-11-492231 · Cited by 616
Lin, Y. C., Jhunjhunwala, S., Benner, C., Heinz, S., Welinder, E., Mansson, R., Sigvardsson, M., Hagman, J., Espinoza, C. A., Dutkowski, J., et al. (2010) · Nature Immunology · doi:10.1038/ni.1891 · Cited by 503
Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors
Cobaleda, C., Jochum, W., & Busslinger, M. (2007) · Nature · doi:10.1038/nature06159 · Cited by 502
The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias
for The St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project, Andersson, A. K., Ma, J., Wang, J., Chen, X., Gedman, A. L., Dang, J., Nakitandwe, J., Holmfeldt, L., Parker, M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3230 · Cited by 490
Kochenderfer, J. N., Yu, Z., Frasheri, D., Restifo, N. P., & Rosenberg, S. A. (2010) · Blood · doi:10.1182/blood-2010-01-265041 · Cited by 391
Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors
Rolink, A. G., Nutt, S. L., Melchers, F., & Busslinger, M. (1999) · Nature · doi:10.1038/44164 · Cited by 386
Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia
Mullighan, C. G., Phillips, L. A., Su, X., Ma, J., Miller, C. B., & Downing, J. R. (2008) · Blood · doi:10.1182/blood.v112.11.429.429 · Cited by 309
Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine
Hunger, S. P., & Mullighan, C. G. (2015) · Blood · doi:10.1182/blood-2015-02-580043 · Cited by 292
Reversion of B Cell Commitment upon Loss of Pax5 Expression
Mikkola, I., Heavey, B., Horcher, M., & Busslinger, M. (2002) · Science · doi:10.1126/science.1067518 · Cited by 291
Lineage switch in acute leukemia
Stass, S., Mirro, J., Melvin, S., Pui, C., Murphy, S., & Williams, D. (1984) · Blood · doi:10.1182/blood.v64.3.701.701 · Cited by 231
Nechanitzky, R., Akbas, D., Scherer, S., Györy, I., Hoyler, T., Ramamoorthy, S., Diefenbach, A., & Grosschedl, R. (2013) · Nature Immunology · doi:10.1038/ni.2641 · Cited by 218
Cell of origin determines clinically relevant subtypes of MLL-rearranged AML
Krivtsov, A. V., Figueroa, M. E., Sinha, A. U., Stubbs, M. C., Feng, Z., Valk, P. J. M., Delwel, R., Döhner, K., Bullinger, L., Kung, A. L., et al. (2013) · Leukemia · doi:10.1038/leu.2012.363 · Cited by 203
Lineage Switch in MLL‐Rearranged Infant Leukemia Following CD19‐Directed Therapy
Rayes, A., McMasters, R. L., & O'Brien, M. M. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.25953 · Cited by 168
Translational implications of somatic genomics in acute myeloid leukaemia
Meyer, S. C., & Levine, R. L. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70008-7 · Cited by 149
Lineage Switching in Acute Leukemias: A Consequence of Stem Cell Plasticity?
Dorantes-Acosta, E. M., & Pelayo, R. (2012) · Bone Marrow Research · doi:10.1155/2012/406796 · Cited by 144
Two distinct auto-regulatory loops operate at the PU.1 locus in B cells and myeloid cells
Leddin, M., Perrod, C., Hoogenkamp, M., Ghani, S., Assi, S., Heinz, S., Wilson, N. K., Follows, G., Schönheit, J., Vockentanz, L., et al. (2011) · Blood · doi:10.1182/blood-2010-08-302976 · Cited by 131
Jacoby, E., Yang, Y., Qin, H., Chien, C. D., Kochenderfer, J. N., & Fry, T. J. (2015) · Blood · doi:10.1182/blood-2015-08-664250 · Cited by 115
Self-citationTargeting Epigenetic Programs in MLL-Rearranged Leukemias
Bernt, K. M., & Armstrong, S. A. (2011) · Hematology · doi:10.1182/asheducation-2011.1.354 · Cited by 110
Evolution to plasmablastic lymphoma evades CD19‐directed chimeric antigen receptor T cells
Evans, A. G., Rothberg, P. G., Burack, R., Huntington, S. F., Porter, D. L., Friedberg, J. W., & Liesveld, J. L. (2015) · British Journal of Haematology · doi:10.1111/bjh.13562 · Cited by 105
Guo, H. W., Ma, O., Speck, N. A., & Friedman, A. D. (2012) · Blood · doi:10.1182/blood-2011-12-397091 · Cited by 99
CD19 is a major B cell receptor–independent activator of MYC-driven B-lymphomagenesis
Chung, E. Y., Psathas, J. N., Yu, D., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci45851 · Cited by 94
Immune-based therapies for childhood cancer
Mackall, C. L., Merchant, M. S., & Fry, T. J. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.177 · Cited by 93
Self-citationHorton, S. J., Jaques, J., Woolthuis, C. M., van Dijk, J., Mesuraca, M., Huls, G. A., Morrone, G., Vellenga, E., & Schuringa, J. J. (2012) · Leukemia · doi:10.1038/leu.2012.343 · Cited by 91
PAX5 is a tumor suppressor in mouse mutagenesis models of acute lymphoblastic leukemia
Dang, J., Wei, L., de Ridder, J., Su, X., Rust, A. G., Roberts, K. G., Payne-Turner, D., Cheng, J., Ma, J., Qu, C., et al. (2015) · Blood · doi:10.1182/blood-2015-02-626127 · Cited by 90
CD19 Function in Central and Peripheral B-Cell Development
Nagro, C. J. D., Otero, D. C., Anzelon-Mills, A. N., Omori, S. A., Kolla, R. V., & Rickert, R. C. (2005) · Immunologic Research · doi:10.1385/ir:31:2:119 · Cited by 89
Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia
Duque‐Afonso, J., Feng, J., Scherer, F., Lin, C.-H., Wong, S. H. K., Wang, Z., 岩崎, 正., & Cleary, M. L. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81158 · Cited by 74
B-cell commitment: deciding on the players
Hardy, R. R. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00012-8 · Cited by 71
Bijl, J. J., Sauvageau, M., Thompson, A., & Sauvageau, G. (2005) · Genes & Development · doi:10.1101/gad.1268505 · Cited by 69
In focus: MLL-rearranged leukemia
de Boer, J., Walf-Vorderwülbecke, V., & Williams, O. (2013) · Leukemia · doi:10.1038/leu.2013.78 · Cited by 63
Yu, D., Allman, D. A., Goldschmidt, M. H., et al. (2003) · Blood · doi:10.1182/blood-2002-06-1797 · Cited by 63
Slámová, L., Starková, J., Froňková, E., Zaliova, M. K., Reznickova, L. R., van Delft, F. W., Vodickova, E., Volejníková, J., Zemanová, Z., Polgárová, K., et al. (2013) · Leukemia · doi:10.1038/leu.2013.354 · Cited by 58
Murine Models of Acute Leukemia: Important Tools in Current Pediatric Leukemia Research
Jacoby, E., Chien, C. D., & Fry, T. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00095 · Cited by 44
Self-citationThe Evolution of B Precursor Leukemia in the Eμ-ret Mouse
Wasserman, R., Zeng, X., & Hardy, R. R. (1998) · Blood · doi:10.1182/blood.v92.1.273.413a32_273_282 · Cited by 39
Stasik, C., Ganguly, S., Cunningham, M. T., Hagemeister, S., & Persons, D. L. (2006) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2006.02.013 · Cited by 32
Shand, J. C., Qin, H., Nasholm, N. M., Capitini, C. M., & Fry, T. J. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.10.009 · Cited by 10
Self-citation
Cited by
Fry, T. J., Shah, N. N., Orentas, R. J., Stetler-Stevenson, M., Yuan, C. M., Ramakrishna, S., Wolters, P., Martin, S., Delbrook, C., Yates, B., et al. (2018) · Nature Medicine · doi:10.1038/nm.4441 · Cited by 1,335
Self-citationThe Principles of Engineering Immune Cells to Treat Cancer
Lim, W. A., & June, C. H. (2017) · Cell · doi:10.1016/j.cell.2017.01.016 · Cited by 1,080
Mechanisms of resistance to CAR T cell therapy
Shah, N. N., & Fry, T. J. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0184-6 · Cited by 959
Self-citationCAR immune cells: design principles, resistance and the next generation
Labanieh, L., & Mackall, C. L. (2023) · Nature · doi:10.1038/s41586-023-05707-3 · Cited by 658
Self-citationClinical lessons learned from the first leg of the CAR T cell journey
Majzner, R. G., & Mackall, C. L. (2019) · Nature Medicine · doi:10.1038/s41591-019-0564-6 · Cited by 636
Self-citation
Metadata
- Authors
- Jacoby, E., Nguyen, S. M., Fountaine, T. J., Welp, K., Gryder, B., Qin, H., Yang, Y., Chien, C. D., Seif, A. E., Lei, H., Song, Y. K., Khan, J., Lee, D. W., Mackall, C. L., Gardner, R. A., Jensen, M. C., Shern, J. F., & Fry, T. J.
- Venue
- Nature Communications
- Published
- 2016-07-27
- Volume
- 7
- Issue
- 1
- Pages
- 12320-12320
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2496398835
- Cited by
- 429
- References
- 51
- FWCI
- 20.55
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.